Suven Pharmaceuticals and Cohance Lifesciences signed a definitive agreement to merge their businesses, which will further strengthen the f...

So from that point of view in the sense, of course, we expect it to be neutral or maybe slightly better but more or less neutral. On the ma...

Eswara Reddy along with Animesh Kumar (Assistant Drugs Inspector), Biocon Biologics' Associate Vice President L Praveen Kumar, and Synergy ...

Orient Cement has entered into a non-binding agreement with Adani Power Maharashtra for setting out the understanding for facilitating bona...

"Though undoubtedly the offence alleged to have been committed (if proved) by the applicants is grave, the trial in the matter would take a...

The agency in its charge sheet filed last week has annexed alleged incriminating WhatsApp texts exchanged between alleged conduit (a woman)...

The special CBI court, in an 80-page order rejecting the bail pleas of all five accused in the case earlier this week, said: "The questions...

The CBI last month arrested Central Drugs Standard Control Organisation (CDSCO) joint drug controller S Eswara Reddy and Biocon Biologics h...

Those arrested include a Joint Drug Controller (JDC), posted at CDSCO Headquarters, New Delhi, an executive of M/s Biocon Biologics Limited...

A special court here had sent all the five accused, including a joint drug controller at Central Drugs Standard Control Organisation, to ju...

CBI has arrested five people including S Eswara Reddy, joint drug controller at CDSCO, L Praveen Kumar, associate vice president and head o...

US District Court of New Jersey found the device patent claims (US Patent No. 9526844) asserted by Sanofi against Biocon and Mylan’s insuli...

Here are a few stocks which may buzz the most in Tuesday's trade.

The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...

CCI’s action is in response to a complaint filed by Mylan and Biocon, who have together developed biosimilar version of Roche’s blockbuster...

Bangalore-based Biocon and US generic drugmaker Mylan have challenged Delhi High Court’s interim order which barred them from using Roche’s...

Roche has sued Mylan, Biocon for launching biosimilar version of the original breast cancer drug, Herceptin, and DCGI for allowing the laun...